Purchase Order 75D30123P18236
Award Date 9/22/23
Potential Completion Date 9/21/24
Potential Value $90K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $96,751.91 contract is for the provision of custom antigens to support assay development work. The award has no set-aside designation. Genscript specializes in supplying a range of molecular biology products and services to various federal agencies, including the Department of Health and Human Services. The...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing, custom design chimeric plasmid, and custom proteins. The $249,785.00 contract has a completion date of September 29, 2022 and was awarded on September 30, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody...
- This is a $54,900 firm fixed-price purchase order awarded to Genscript USA Inc., a biotechnology company based in New Jersey, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The contract is for the delivery of "AM MAG QUATTRO" products, with a period of performance through September 29, 2024. Genscript is a well-established provider of molecular biology services to various federal agencies, including the Department of Health and Human Services, Department...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $248,857.00 Firm Fixed Price purchase order to Genscript USA Inc., a biotechnology company, for the provision of "FAST GENE SYNTHESIS" services. The contract has an August 7, 2023 completion date and was awarded on August 8, 2022. Genscript is a for-profit organization that provides gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services to...
- This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for stable cell line development services with a completion date of April 1, 2020. The contract had a potential value of $130,400.99 and was not set aside for any particular business type. Genscript provides a range of molecular biology products and services, including gene synthesis, gene editing,...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $164,700.00 firm fixed-price purchase order is for monoclonal antibodies and plasmids services, with a completion date of June 14, 2026. The contract does not have a set-aside designation. Genscript is a key supplier of...
- This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for the delivery of custom rabbit monoclonal antibodies to support the development of diagnostic tests for taeniasis and cysticercosis. The award, valued at $49,981.00, was made by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and has a period of performance from September 30, 2024 to April 22, 2025. The original solicitation, a Request for Quotations (RFQ), was...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...